API Intermediates & Bulk Drug Mfg Unit For Sale In Hyderabad

About Business

The company is involved in manufacturing pharmaceutical intermediates, bulk drugs, specialty chemicals, and fine chemical products used in the pharma industry. The business mainly focuses on process-driven manufacturing for API intermediates and related chemical compounds.

The manufacturing unit is located in a well-known pharmaceutical industrial area in South India and is equipped for handling multiple products under one setup. The operations include intermediate manufacturing, custom synthesis, and specialty chemical processing.

Product Portfolio

The company manufactures intermediates and related compounds for pharmaceutical products such as:

Lopinavir
Irbesartan
Cilastatin
Ceftibuten
Meropenem
Pregabalin
Ezogabine
Cefuroxime intermediates
Grignard reagents
Specialty API intermediates

The business is associated with nearly 20 APIs and intermediate products, covering both intermediate-stage and advanced-stage pharmaceutical compounds.

Manufacturing Capabilities
API intermediate manufacturing
Bulk drug production
Specialty and fine chemical manufacturing
Multi-product manufacturing facility
Custom synthesis support
Process-based chemical manufacturing
Contract manufacturing activities
Facility Details

The facility is designed for pharmaceutical intermediate and specialty chemical manufacturing activities. The setup supports production across different product categories and includes infrastructure suitable for process manufacturing operations.

Business Strengths
Operational pharmaceutical manufacturing setup
Experience in advanced intermediates
Diversified product range
Existing plant and machinery infrastructure
Technical knowledge in process manufacturing
Presence in a major pharmaceutical manufacturing zone

Clientele type

The company supplies products to several established pharmaceutical and chemical companies, including leading domestic and international players. The customer base includes reputed industry names such as Aurobindo, Viatris, Laurus, Cadila, Clariant, and Sarex, along with around 15 active customers comprising mid-sized and large pharmaceutical businesses.

The company has also developed export exposure and completed export shipments to Nigeria during FY 2024–25, supplying approximately 6 tons of products.

Premises

OWNED

Premise Size: 6.17 ACRES

Market Value (in INR): 56.00 Cr

The manufacturing unit is spread across 6.17 acres of land and holds all required government approvals and operational licenses, including Environmental Clearance (E.C.), Consent for Establishment (CFE), Consent for Operation (CFO), and other necessary statutory permissions.

Asking Price Includes

The transaction includes the transfer of product technologies, company ownership, licenses, manufacturing assets, and the building infrastructure.

Reason

The promoters are currently focused on their other business operations and are therefore looking for an exit from this business.

Licenses

Trade License, Consent for Establishment (CFE), Consent for Operation (CFO), Environmental Clearance (E.C.), and all major statutory licenses